Luca Sigalotti

3.6k total citations
61 papers, 2.6k citations indexed

About

Luca Sigalotti is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Luca Sigalotti has authored 61 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 33 papers in Immunology and 17 papers in Oncology. Recurrent topics in Luca Sigalotti's work include Immunotherapy and Immune Responses (29 papers), Epigenetics and DNA Methylation (24 papers) and Immune Cell Function and Interaction (12 papers). Luca Sigalotti is often cited by papers focused on Immunotherapy and Immune Responses (29 papers), Epigenetics and DNA Methylation (24 papers) and Immune Cell Function and Interaction (12 papers). Luca Sigalotti collaborates with scholars based in Italy, United States and Australia. Luca Sigalotti's co-authors include Michele Maio, Sandra Coral, Francesca Colizzi, Maresa Altomonte, Elisabetta Fratta, Alessia Covre, Ester Fonsatti, Riccardo Danielli, Hugues J. M. Nicolay and Giulia Parisi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Luca Sigalotti

61 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luca Sigalotti Italy 28 1.7k 1.1k 813 294 207 61 2.6k
Sandra Coral Italy 25 1.6k 0.9× 1.1k 0.9× 691 0.8× 270 0.9× 195 0.9× 53 2.3k
Luigi Scotto United States 30 1.5k 0.9× 1.1k 0.9× 642 0.8× 280 1.0× 121 0.6× 82 2.8k
Francesca Colizzi Italy 23 1.3k 0.7× 881 0.8× 537 0.7× 216 0.7× 139 0.7× 40 1.8k
Henry Koon United States 25 1.4k 0.8× 910 0.8× 1.3k 1.6× 240 0.8× 282 1.4× 59 2.9k
Håkan Hedman Sweden 28 1.5k 0.9× 493 0.4× 601 0.7× 328 1.1× 188 0.9× 71 2.3k
Julie S. Nielsen Canada 20 686 0.4× 959 0.8× 927 1.1× 207 0.7× 139 0.7× 26 2.0k
Stefania Canè Italy 23 619 0.4× 768 0.7× 698 0.9× 310 1.1× 197 1.0× 39 2.0k
Katie A. Matatall United States 13 987 0.6× 693 0.6× 672 0.8× 235 0.8× 234 1.1× 16 2.2k
Maria Valeria Corrias Italy 29 1.1k 0.6× 1.1k 1.0× 1.1k 1.3× 696 2.4× 104 0.5× 108 2.9k
Ajay K. Malik United States 10 1.1k 0.7× 437 0.4× 590 0.7× 436 1.5× 152 0.7× 16 1.8k

Countries citing papers authored by Luca Sigalotti

Since Specialization
Citations

This map shows the geographic impact of Luca Sigalotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Sigalotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Sigalotti more than expected).

Fields of papers citing papers by Luca Sigalotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Sigalotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Sigalotti. The network helps show where Luca Sigalotti may publish in the future.

Co-authorship network of co-authors of Luca Sigalotti

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Sigalotti. A scholar is included among the top collaborators of Luca Sigalotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Sigalotti. Luca Sigalotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muraro, Elena, Barbara Montico, Benedict Lum, et al.. (2024). Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors. Frontiers in Immunology. 15. 1336566–1336566. 2 indexed citations
2.
Frezza, Anna Maria, Luca Sigalotti, Marta Sbaraglia, et al.. (2020). Epitheliod sarcoma: Molecular insights into proximal versus classic variant.. Journal of Clinical Oncology. 38(15_suppl). e23552–e23552. 3 indexed citations
3.
Montico, Barbara, Francesca Colizzi, Giorgio Giurato, et al.. (2020). Loss of Spry1 reduces growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy. Cell Death and Disease. 11(5). 392–392. 13 indexed citations
4.
Furlan, Carlo, Jerry Polesel, Luigi Barzan, et al.. (2017). Prognostic significance of LINE-1 hypomethylation in oropharyngeal squamous cell carcinoma. Clinical Epigenetics. 9(1). 58–58. 31 indexed citations
5.
Montico, Barbara, Luca Sigalotti, Maurilio Ponzoni, et al.. (2016). Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma. Oncotarget. 7(27). 41913–41928. 16 indexed citations
6.
Maio, Michele, Alessia Covre, Elisabetta Fratta, et al.. (2015). Molecular Pathways: At the Crossroads of Cancer Epigenetics and Immunotherapy. Clinical Cancer Research. 21(18). 4040–4047. 77 indexed citations
7.
Sigalotti, Luca, Elisabetta Fratta, Sandra Coral, & Michele Maio. (2014). Epigenetic drugs as immunomodulators for combination therapies in solid tumors. Pharmacology & Therapeutics. 142(3). 339–350. 78 indexed citations
8.
Sigalotti, Luca, Elisabetta Fratta, Giulia Parisi, Sandra Coral, & Michele Maio. (2013). Epigenetic Markers of Prognosis in Melanoma. Methods in molecular biology. 1102. 481–499. 8 indexed citations
9.
Maio, Michele, Gavin Choy, Alessia Covre, et al.. (2013). Immunomodulatory Activity of SGI-110, a Second Generation Hypomethylating Agent. Annals of Oncology. 24. i7–i7. 1 indexed citations
10.
Sigalotti, Luca, Alessia Covre, Elisabetta Fratta, et al.. (2012). Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients. Journal of Translational Medicine. 10(1). 185–185. 43 indexed citations
11.
Calabrò, Luana, Riccardo Danielli, Luca Sigalotti, & Michele Maio. (2010). Clinical Studies With Anti–CTLA-4 Antibodies in Non-melanoma Indications. Seminars in Oncology. 37(5). 460–467. 45 indexed citations
12.
Sigalotti, Luca, Alessia Covre, Susan E. Zabierowski, et al.. (2008). Cancer testis antigens in human melanoma stem cells: Expression, distribution, and methylation status. Journal of Cellular Physiology. 215(2). 287–291. 48 indexed citations
13.
Beffagna, Giorgia, Marzia De Bortoli, Andrea Nava, et al.. (2007). Missense mutations in Desmocollin-2 N-terminus, associated with arrhythmogenic right ventricular cardiomyopathy, affect intracellular localization of desmocollin-2 in vitro. BMC Medical Genetics. 8(1). 65–65. 60 indexed citations
14.
Calabrò, Luana, Ester Fonsatti, Maresa Altomonte, et al.. (2004). Methylation‐regulated expression of cancer testis antigens in primary effusion lymphoma: Immunotherapeutic implications. Journal of Cellular Physiology. 202(2). 474–477. 22 indexed citations
15.
Fonsatti, Ester, Luca Sigalotti, Perihan Arslan, Maresa Altomonte, & Michele Maio. (2003). Emerging Role of Endoglin (CD105) as a Marker of Angiogenesis with Clinical Potential in Human Malignancies. Current Cancer Drug Targets. 3(6). 427–432. 79 indexed citations
16.
Maio, Michele, Sandra Coral, Elisabetta Fratta, Maresa Altomonte, & Luca Sigalotti. (2003). Epigenetic targets for immune intervention in human malignancies. Oncogene. 22(42). 6484–6488. 58 indexed citations
17.
Sigalotti, Luca, Sandra Coral, Maresa Altomonte, et al.. (2002). Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications. British Journal of Cancer. 86(6). 979–982. 71 indexed citations
18.
Giordano, Giovan Giacomo, Luca Sigalotti, & Michele Maio. (2002). Adjuncts in diagnosis, prognosis, and clinical monitoring of breast, gynecologic, and hematolymphopoietic malignancies: Third joint international workshop, Lacco Ameno d'Ischia, Italy, October 2001*. Journal of Cellular Physiology. 191(3). 362–365. 1 indexed citations
19.
Fonsatti, Ester, Luigi Del Vecchio, Maresa Altomonte, et al.. (2001). Endoglin: An accessory component of the TGF‐β‐binding receptor‐complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies. Journal of Cellular Physiology. 188(1). 1–7. 151 indexed citations
20.
Gasparollo, Aldo, Sandra Coral, Marina Ciullo, et al.. (2001). Unbalanced expression of HLA-A and -B antigens: A specific feature of cutaneous melanoma and other non-hemopoietic malignancies reverted by IFN-?. International Journal of Cancer. 91(4). 500–507. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandra Coral Breakdown of academic impact, for papers by Luigi Scotto Breakdown of academic impact, for papers by Francesca Colizzi Breakdown of academic impact, for papers by Henry Koon Breakdown of academic impact, for papers by Håkan Hedman Breakdown of academic impact, for papers by Julie S. Nielsen Breakdown of academic impact, for papers by Stefania Canè Breakdown of academic impact, for papers by Katie A. Matatall Breakdown of academic impact, for papers by Maria Valeria Corrias Breakdown of academic impact, for papers by Ajay K. Malik
Rankless by CCL
2026